$INVA
Innoviva, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$20.50
▼-0.24%-$0.050
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateInnoviva, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is INVA down today? It is at $20.50 (-0.24%), and our scanner flagged it 25 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INVA spikes, and full due diligence on INVA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $INVA 25 times in the last 30 days. Create a free account to track $INVA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on INVA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INVA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystInnoviva, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 24, 2026 · 41 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Raifeld Pavel Officer | Sold (automatic/other) | -1K | sold 0.4% | 285K | $24K at $21.00 | Aug 20, 26 |
Basso Stephen Officer | Sold (automatic/other) | -558 | sold 0.6% | 88K | $12K at $21.00 | Aug 20, 26 |
Zhen Marianne Officer | Sold (automatic/other) | -1K | sold 2.0% | 56K | $24K at $21.00 | Aug 20, 26 |
Zhen Marianne Officer | Sold (automatic/other) | -1K | sold 1.9% | 58K | $25K at $22.24 | May 20, 26 |
Raifeld Pavel Officer | Sold (automatic/other) | -1K | sold 0.4% | 286K | $25K at $22.24 | May 20, 26 |
Basso Stephen Officer | Sold (automatic/other) | -559 | sold 0.6% | 89K | $12K at $22.24 | May 20, 26 |
Linden Josephine Director | Acquired (grant/award) | +15K 0.02% of company | n/a | 15K | n/a | May 18, 26 |
Raifeld Pavel Officer | Acquired (grant/award) | +1K | added 0.4% | 287K | n/a | May 15, 26 |
Basso Stephen Officer | Acquired (grant/award) | +1K | added 1.3% | 89K | n/a | May 15, 26 |
Haimovitz Jules Director | Acquired (grant/award) | +10K 0.01% of company | added 6.8% | 153K | n/a | May 4, 26 |
Small Derek A Director | Acquired (grant/award) | +10K 0.01% of company | added 28% | 45K | n/a | May 4, 26 |
Schlesinger Sarah J. Director | Acquired (grant/award) | +10K 0.01% of company | added 7.5% | 140K | n/a | May 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on INVA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INVA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
INVA last traded at $20.50, down 0.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Innoviva, Inc. Common Stock (INVA) is next expected to report earnings on Wednesday, November 4, 2026, about 30 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. INVA currently has a dividend yield of about 4.88% ($1.00 per share per year). Dividend figures can change; this is not investment advice.
The INVA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INVA 25 times in the last 30 days.
INVA (Innoviva, Inc. Common Stock) trades on XNAS, with a market cap of about $1.48B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INVA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$INVA discussion
Sign in to ask a question or join the discussion.